RESMED INC — Director's Dealing 2010

Nov 16, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-12

Reporting Person: Douglas Robert Andrew (COO Asia Pacific)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-12	ResMed Common Stock	M	10000	$18.67	Acquired	54407.484	Direct
2010-11-12	ResMed Common Stock	S	10000	$33.51	Disposed	44756.57	Direct
2010-11-12	ResMed Common Stock	S	10000	$33.51	Disposed	34756.57	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-11-12	ResMed Common Stock Options	$18.67	M	10000	Acquired	2015-08-01	ResMed Common Stock (10000)	Direct

Footnotes

F1: Represents first date shares became exercisable.

F2: This transaction was executed in multiple trades at prices ranging from $33.50 to $33.52. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: Includes 349.086 shares purchased on October 30, 2010, pursuant to ResMed's Employee Stock Purchase Plan.